Concepts (281)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gluconeogenesis | 14 | 2024 | 93 | 2.300 |
Why?
|
| Insulin Resistance | 16 | 2023 | 669 | 1.530 |
Why?
|
| Glucose | 17 | 2024 | 842 | 1.360 |
Why?
|
| Parenteral Nutrition | 7 | 2025 | 214 | 0.650 |
Why?
|
| Glycine | 5 | 2025 | 161 | 0.580 |
Why?
|
| Lipodystrophy | 4 | 2023 | 32 | 0.580 |
Why?
|
| Energy Metabolism | 4 | 2024 | 763 | 0.570 |
Why?
|
| Insulin | 11 | 2023 | 1131 | 0.550 |
Why?
|
| Glycogenolysis | 3 | 2018 | 10 | 0.530 |
Why?
|
| Bile Acids and Salts | 5 | 2025 | 243 | 0.520 |
Why?
|
| Cholestasis | 4 | 2025 | 164 | 0.520 |
Why?
|
| Obesity, Morbid | 3 | 2025 | 196 | 0.490 |
Why?
|
| Blood Glucose | 16 | 2024 | 1087 | 0.490 |
Why?
|
| Parenteral Nutrition, Total | 3 | 2011 | 114 | 0.470 |
Why?
|
| Infant, Premature | 4 | 2023 | 823 | 0.420 |
Why?
|
| Digestion | 3 | 2020 | 42 | 0.400 |
Why?
|
| Liver | 7 | 2025 | 1764 | 0.400 |
Why?
|
| Fat Emulsions, Intravenous | 4 | 2021 | 79 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2024 | 1354 | 0.390 |
Why?
|
| Hyperglycemia | 4 | 2018 | 225 | 0.380 |
Why?
|
| Ghrelin | 1 | 2012 | 57 | 0.360 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2025 | 319 | 0.350 |
Why?
|
| Bariatric Surgery | 2 | 2024 | 126 | 0.350 |
Why?
|
| Metformin | 2 | 2024 | 157 | 0.330 |
Why?
|
| Deuterium Oxide | 2 | 2020 | 17 | 0.320 |
Why?
|
| Dietary Supplements | 3 | 2025 | 438 | 0.320 |
Why?
|
| Intestines | 2 | 2025 | 578 | 0.310 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2020 | 72 | 0.310 |
Why?
|
| Fasting | 4 | 2022 | 300 | 0.310 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2010 | 168 | 0.300 |
Why?
|
| Methionine | 4 | 2011 | 90 | 0.300 |
Why?
|
| Fatty Acids | 3 | 2020 | 351 | 0.300 |
Why?
|
| Glucose Intolerance | 2 | 2022 | 83 | 0.290 |
Why?
|
| Starch | 3 | 2020 | 25 | 0.280 |
Why?
|
| Liver Diseases | 3 | 2019 | 381 | 0.280 |
Why?
|
| Premature Birth | 3 | 2022 | 415 | 0.280 |
Why?
|
| Animals, Newborn | 7 | 2025 | 1014 | 0.280 |
Why?
|
| alpha-Glucosidases | 2 | 2020 | 30 | 0.270 |
Why?
|
| Vitamin E | 2 | 2019 | 62 | 0.270 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 353 | 0.250 |
Why?
|
| Soybean Oil | 4 | 2021 | 71 | 0.250 |
Why?
|
| Glutathione | 4 | 2025 | 195 | 0.250 |
Why?
|
| Swine | 7 | 2025 | 1164 | 0.250 |
Why?
|
| Sucrase-Isomaltase Complex | 2 | 2017 | 19 | 0.240 |
Why?
|
| Intestinal Mucosa | 3 | 2025 | 754 | 0.240 |
Why?
|
| Carbon Isotopes | 5 | 2020 | 230 | 0.240 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2024 | 14 | 0.220 |
Why?
|
| Dietary Carbohydrates | 2 | 2016 | 107 | 0.220 |
Why?
|
| Benzoic Acid | 1 | 2024 | 3 | 0.220 |
Why?
|
| Thermogenesis | 1 | 2024 | 50 | 0.210 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 84 | 0.210 |
Why?
|
| Adipose Tissue, White | 1 | 2024 | 88 | 0.210 |
Why?
|
| Enteral Nutrition | 3 | 2023 | 279 | 0.210 |
Why?
|
| Phytosterols | 2 | 2021 | 28 | 0.200 |
Why?
|
| Animals | 22 | 2025 | 33120 | 0.200 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 1 | 2022 | 5 | 0.200 |
Why?
|
| Leptin | 2 | 2023 | 218 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 4496 | 0.190 |
Why?
|
| Hypoglycemic Agents | 3 | 2024 | 458 | 0.190 |
Why?
|
| Adipose Tissue | 3 | 2020 | 475 | 0.190 |
Why?
|
| Sus scrofa | 4 | 2019 | 114 | 0.180 |
Why?
|
| Exercise | 2 | 2019 | 837 | 0.180 |
Why?
|
| Male | 25 | 2025 | 62089 | 0.170 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2022 | 71 | 0.170 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2020 | 74 | 0.170 |
Why?
|
| Aging | 3 | 2024 | 1187 | 0.170 |
Why?
|
| Muscle Strength | 1 | 2021 | 79 | 0.170 |
Why?
|
| Receptor, Insulin | 1 | 2020 | 58 | 0.160 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2018 | 113 | 0.160 |
Why?
|
| Acetylcysteine | 1 | 2021 | 79 | 0.160 |
Why?
|
| Incretins | 1 | 2020 | 26 | 0.160 |
Why?
|
| Lipolysis | 1 | 2020 | 73 | 0.160 |
Why?
|
| Oxidation-Reduction | 6 | 2020 | 424 | 0.160 |
Why?
|
| Lipogenesis | 1 | 2020 | 63 | 0.160 |
Why?
|
| Homeostasis | 2 | 2021 | 686 | 0.160 |
Why?
|
| Humans | 35 | 2025 | 126089 | 0.160 |
Why?
|
| Female | 26 | 2025 | 67915 | 0.160 |
Why?
|
| Gastrectomy | 1 | 2020 | 98 | 0.160 |
Why?
|
| Barth Syndrome | 1 | 2019 | 1 | 0.150 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2010 | 65 | 0.150 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2011 | 161 | 0.150 |
Why?
|
| Phospholipids | 1 | 2019 | 99 | 0.150 |
Why?
|
| Rifampin | 1 | 2019 | 117 | 0.150 |
Why?
|
| Alanine | 3 | 2023 | 162 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2020 | 415 | 0.140 |
Why?
|
| Fatty Liver | 1 | 2020 | 204 | 0.140 |
Why?
|
| Proglucagon | 1 | 2017 | 5 | 0.140 |
Why?
|
| Infant, Newborn | 6 | 2023 | 8358 | 0.140 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 2017 | 5 | 0.140 |
Why?
|
| Glucagon | 3 | 2017 | 146 | 0.140 |
Why?
|
| Sucrase | 1 | 2017 | 23 | 0.140 |
Why?
|
| Homocysteine | 4 | 2011 | 118 | 0.140 |
Why?
|
| Isothiocyanates | 1 | 2017 | 11 | 0.130 |
Why?
|
| Adult | 15 | 2025 | 30254 | 0.130 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2017 | 39 | 0.130 |
Why?
|
| Gastrointestinal Agents | 1 | 2017 | 61 | 0.130 |
Why?
|
| Leucine | 3 | 2023 | 258 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2021 | 754 | 0.120 |
Why?
|
| Bicycling | 1 | 2016 | 35 | 0.120 |
Why?
|
| Cognition | 1 | 2021 | 783 | 0.120 |
Why?
|
| Models, Biological | 3 | 2016 | 1370 | 0.120 |
Why?
|
| Thinness | 1 | 2016 | 69 | 0.120 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2016 | 51 | 0.120 |
Why?
|
| Inflammation | 2 | 2021 | 1418 | 0.120 |
Why?
|
| Serine | 1 | 2016 | 161 | 0.110 |
Why?
|
| Diet, Protein-Restricted | 1 | 2016 | 80 | 0.110 |
Why?
|
| Microbiota | 1 | 2020 | 426 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 238 | 0.110 |
Why?
|
| Mice | 8 | 2024 | 17585 | 0.110 |
Why?
|
| Swine Diseases | 1 | 2014 | 40 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 229 | 0.100 |
Why?
|
| Calorimetry, Indirect | 3 | 2021 | 63 | 0.100 |
Why?
|
| Amino Acids | 3 | 2023 | 615 | 0.100 |
Why?
|
| Fish Oils | 3 | 2021 | 82 | 0.090 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2023 | 167 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 606 | 0.090 |
Why?
|
| Food Deprivation | 1 | 2012 | 34 | 0.090 |
Why?
|
| Receptors, Ghrelin | 1 | 2012 | 29 | 0.090 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2011 | 5 | 0.090 |
Why?
|
| Muscle, Skeletal | 3 | 2023 | 979 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 90 | 0.090 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2011 | 44 | 0.090 |
Why?
|
| Young Adult | 6 | 2021 | 9616 | 0.080 |
Why?
|
| Adolescent | 8 | 2024 | 19936 | 0.080 |
Why?
|
| Emulsions | 2 | 2021 | 69 | 0.080 |
Why?
|
| Gestational Age | 2 | 2015 | 1198 | 0.080 |
Why?
|
| Isotope Labeling | 3 | 2020 | 93 | 0.080 |
Why?
|
| Hydrocortisone | 1 | 2011 | 221 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2024 | 3303 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2015 | 527 | 0.080 |
Why?
|
| Colitis | 1 | 2011 | 157 | 0.080 |
Why?
|
| Amino Acids, Sulfur | 1 | 2009 | 15 | 0.080 |
Why?
|
| Craniosynostoses | 1 | 2011 | 139 | 0.070 |
Why?
|
| Abdomen | 1 | 2009 | 131 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 638 | 0.070 |
Why?
|
| Birth Weight | 1 | 2010 | 340 | 0.070 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 2 | 2021 | 32 | 0.070 |
Why?
|
| Methenamine | 1 | 2008 | 7 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 440 | 0.070 |
Why?
|
| Lactation | 1 | 2009 | 194 | 0.070 |
Why?
|
| Body Water | 1 | 2008 | 87 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2013 | 3706 | 0.070 |
Why?
|
| Glucose Tolerance Test | 2 | 2018 | 199 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 3649 | 0.070 |
Why?
|
| Radioactive Tracers | 1 | 2006 | 20 | 0.060 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 45 | 0.060 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2025 | 18 | 0.060 |
Why?
|
| Obesity | 3 | 2024 | 2330 | 0.060 |
Why?
|
| Critical Illness | 1 | 2009 | 603 | 0.060 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2024 | 6 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2007 | 218 | 0.060 |
Why?
|
| Triglycerides | 2 | 2020 | 597 | 0.060 |
Why?
|
| Mitochondria | 2 | 2021 | 731 | 0.060 |
Why?
|
| Dioxoles | 1 | 2024 | 12 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2009 | 869 | 0.060 |
Why?
|
| Middle Aged | 5 | 2025 | 27331 | 0.060 |
Why?
|
| Uncoupling Protein 1 | 1 | 2024 | 31 | 0.060 |
Why?
|
| Biomarkers | 3 | 2021 | 3138 | 0.050 |
Why?
|
| Hippurates | 1 | 2024 | 7 | 0.050 |
Why?
|
| Pregnancy | 4 | 2021 | 7404 | 0.050 |
Why?
|
| Liraglutide | 1 | 2024 | 13 | 0.050 |
Why?
|
| Palmitates | 1 | 2023 | 17 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 2875 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2022 | 1649 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1125 | 0.050 |
Why?
|
| Glycerol | 1 | 2023 | 80 | 0.050 |
Why?
|
| Child | 6 | 2021 | 25062 | 0.050 |
Why?
|
| Carbon | 1 | 2023 | 88 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2023 | 143 | 0.050 |
Why?
|
| Cholic Acid | 1 | 2022 | 19 | 0.050 |
Why?
|
| Diet | 3 | 2020 | 1102 | 0.050 |
Why?
|
| Glycine Agents | 1 | 2021 | 10 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2022 | 264 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2021 | 53 | 0.040 |
Why?
|
| Endothelium | 1 | 2021 | 63 | 0.040 |
Why?
|
| Keto Acids | 1 | 2020 | 50 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2012 | 324 | 0.040 |
Why?
|
| Peptide YY | 1 | 2020 | 19 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2012 | 2968 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 2012 | 525 | 0.040 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2020 | 19 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 162 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 415 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 182 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 565 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 397 | 0.040 |
Why?
|
| Hyperbilirubinemia | 1 | 2019 | 41 | 0.040 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2019 | 47 | 0.040 |
Why?
|
| Glucuronosyltransferase | 1 | 2019 | 63 | 0.040 |
Why?
|
| Palmitic Acid | 1 | 2018 | 28 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 4468 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 418 | 0.040 |
Why?
|
| Amino Acids, Essential | 1 | 2018 | 22 | 0.040 |
Why?
|
| Tritium | 2 | 2009 | 111 | 0.040 |
Why?
|
| Glucose Clamp Technique | 1 | 2018 | 77 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 1225 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2021 | 424 | 0.040 |
Why?
|
| Gene Expression | 2 | 2014 | 1485 | 0.040 |
Why?
|
| Exercise Test | 1 | 2019 | 239 | 0.030 |
Why?
|
| DNA Damage | 1 | 2021 | 492 | 0.030 |
Why?
|
| Shrews | 1 | 2017 | 5 | 0.030 |
Why?
|
| Methylation | 2 | 2009 | 197 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2017 | 32 | 0.030 |
Why?
|
| Sulfoxides | 1 | 2017 | 10 | 0.030 |
Why?
|
| India | 1 | 2018 | 228 | 0.030 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2017 | 46 | 0.030 |
Why?
|
| Kinetics | 2 | 2009 | 1090 | 0.030 |
Why?
|
| China | 1 | 2018 | 274 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2018 | 194 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2021 | 1386 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 414 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2017 | 101 | 0.030 |
Why?
|
| Glycogen | 1 | 2016 | 50 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 326 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2016 | 32 | 0.030 |
Why?
|
| Energy Intake | 1 | 2018 | 495 | 0.030 |
Why?
|
| Athletes | 1 | 2016 | 70 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 120 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2016 | 119 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2017 | 666 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 306 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2772 | 0.030 |
Why?
|
| Cholestenones | 1 | 2014 | 7 | 0.030 |
Why?
|
| Olive Oil | 1 | 2014 | 24 | 0.030 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2014 | 49 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 452 | 0.030 |
Why?
|
| Plant Oils | 1 | 2014 | 32 | 0.030 |
Why?
|
| Postprandial Period | 1 | 2013 | 88 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1098 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6093 | 0.020 |
Why?
|
| Algorithms | 2 | 2009 | 1619 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 2565 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 867 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 4920 | 0.020 |
Why?
|
| Sex Factors | 1 | 2016 | 1294 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2311 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 1014 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2013 | 286 | 0.020 |
Why?
|
| Infant | 3 | 2012 | 12762 | 0.020 |
Why?
|
| Pyridoxal Phosphate | 1 | 2011 | 12 | 0.020 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2011 | 16 | 0.020 |
Why?
|
| Methylmalonic Acid | 1 | 2011 | 15 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2011 | 47 | 0.020 |
Why?
|
| Peroxidase | 1 | 2011 | 60 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 549 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 180 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6552 | 0.020 |
Why?
|
| Hexoses | 1 | 2009 | 10 | 0.020 |
Why?
|
| Ketone Bodies | 1 | 2009 | 38 | 0.020 |
Why?
|
| Lactates | 1 | 2009 | 77 | 0.020 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2009 | 4 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 947 | 0.020 |
Why?
|
| Nitrogen Isotopes | 1 | 2009 | 45 | 0.020 |
Why?
|
| C-Peptide | 1 | 2009 | 93 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 2009 | 65 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4409 | 0.020 |
Why?
|
| Kidney | 1 | 2015 | 1279 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 1025 | 0.020 |
Why?
|
| Cysteine | 1 | 2009 | 137 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2009 | 271 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2902 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2009 | 101 | 0.020 |
Why?
|
| Organ Size | 1 | 2009 | 435 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 1919 | 0.020 |
Why?
|
| Cell Division | 1 | 2009 | 719 | 0.020 |
Why?
|
| Metabolomics | 1 | 2011 | 455 | 0.020 |
Why?
|
| Sulfur Compounds | 1 | 2007 | 5 | 0.020 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2007 | 14 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 970 | 0.020 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2006 | 36 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 826 | 0.020 |
Why?
|
| Capillaries | 1 | 2006 | 68 | 0.020 |
Why?
|
| Milk, Human | 1 | 2009 | 308 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 602 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2012 | 14329 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3680 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 2936 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 20005 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6016 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12328 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 5926 | 0.010 |
Why?
|